ISOPROPYL ALCOHOL

ISOPROPYL ALCOHOL was reported 33774 times

ISOPROPYL ALCOHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 120 0.5240
1 EX-DRUG ABUSER 13 0.4815
2 BLOOD ETHANOL 18 0.4286
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 268 0.4012
4 LUPUS VULGARIS 469 0.3722
5 POSTMORTEM BLOOD DRUG LEVEL 21 0.3559
6 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 169 0.3012
7 SWOLLEN JOINT COUNT 74 0.2960
8 ALCOHOL INTERACTION 574 0.2951
9 VICTIM OF CRIME 354 0.2862
10 ALCOHOL TEST POSITIVE 13 0.2766
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 538 0.2686
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 534 0.2575
13 SWOLLEN JOINT COUNT INCREASED 815 0.2553
14 RHEUMATIC FEVER 1113 0.2494
15 POSTMORTEM BLOOD DRUG LEVEL ABNORMAL 36 0.2449
16 C-REACTIVE PROTEIN 224 0.2416
17 CHEMICAL SUBMISSION 59 0.2332
18 DISLOCATION OF VERTEBRA 517 0.2265
19 FACET JOINT SYNDROME 732 0.2246
20 X-RAY ABNORMAL 401 0.2240
21 BEHAVIOURAL ADDICTION 14 0.2222
22 HEPATIC ENZYME 32 0.2148
23 ACQUIRED PORPHYRIA 15 0.2113
24 ALCOHOL ABUSE 513 0.1916
25 RETINITIS 327 0.1891
26 DUODENAL ULCER PERFORATION 1367 0.1836
27 FOETAL ALCOHOL SYNDROME 18 0.1800
28 ALCOHOL POISONING 453 0.1690
29 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1207 0.1683
30 RHEUMATOID FACTOR POSITIVE 964 0.1667
31 MUSCLE INJURY 1265 0.1525
32 BLOOD ALCOHOL INCREASED 119 0.1520
33 PORPHYRIA ACUTE 214 0.1491
34 HELICOBACTER INFECTION 1474 0.1433
35 SUBSTANCE USE DISORDER 440 0.1380
36 FOLLICULITIS 1443 0.1375
37 BLOOD ETHANOL INCREASED 30 0.1364
38 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 885 0.1361
39 POLYSUBSTANCE DEPENDENCE 23 0.1345
40 SUSPECTED SUICIDE 608 0.1296
41 PERIPHERAL VENOUS DISEASE 520 0.1272
42 SUBSTANCE DEPENDENCE 83 0.1233
43 C-REACTIVE PROTEIN ABNORMAL 773 0.1204
44 PEMPHIGUS 1495 0.1195
45 VICTIM OF SEXUAL ABUSE 62 0.1179
46 HAND DEFORMITY 1475 0.1123
47 EXPOSURE TO TOXIC AGENT 337 0.1052
48 SUBSTANCE ABUSE 844 0.1036
49 BONE EROSION 360 0.1017
50 ALCOHOLIC 19 0.0955
51 SERONEGATIVE ARTHRITIS 106 0.0925
52 BREAST CANCER STAGE III 592 0.0913
53 PERICARDITIS 1460 0.0868
54 ALCOHOL WITHDRAWAL SYNDROME 72 0.0828
55 ALCOHOL USE DISORDER 14 0.0819
56 LIP DRY 744 0.0818
57 HANGING 16 0.0808
58 HYPERCHOLESTEROLAEMIA 762 0.0788
59 SYNOVITIS 1387 0.0768
60 ONYCHOMADESIS 321 0.0764
61 ALCOHOL USE 281 0.0761
62 HOMICIDE 140 0.0759
63 GRIP STRENGTH DECREASED 666 0.0756
64 JOINT RANGE OF MOTION DECREASED 1013 0.0755
65 POSTMORTEM BLOOD DRUG LEVEL INCREASED 28 0.0751
66 ADULTERATED PRODUCT 15 0.0750
67 SUBSTANCE ABUSER 17 0.0749
68 CHILD NEGLECT 18 0.0747
69 OPIATES POSITIVE 35 0.0729
70 IRRITABLE BOWEL SYNDROME 1480 0.0690
71 ONYCHOMYCOSIS 298 0.0679
72 GLOSSODYNIA 1497 0.0668
73 COMPLETED SUICIDE 5465 0.0655
74 ALCOHOL PROBLEM 16 0.0653
75 VICTIM OF HOMICIDE 38 0.0653
76 WOUND INFECTION 713 0.0650
77 DRUG ABUSE 5347 0.0642
78 SEXUAL ABUSE 28 0.0632
79 TOXICOLOGIC TEST ABNORMAL 37 0.0611
80 ALCOHOL INTOLERANCE 43 0.0606
81 HYPOCHOLESTEROLAEMIA 21 0.0595
82 VICTIM OF CHEMICAL SUBMISSION 39 0.0581
83 CONGESTIVE HEPATOPATHY 26 0.0580
84 BREATH ALCOHOL TEST POSITIVE 13 0.0578
85 SLEEP WALKING 33 0.0573
86 DRUG USE DISORDER 475 0.0564
87 DRUG TOLERANCE DECREASED 157 0.0559
88 BURSITIS 645 0.0531
89 WOUND 1462 0.0523
90 AUTOIMMUNE DISORDER 508 0.0521
91 PUSTULAR PSORIASIS 174 0.0506
92 MULTIPLE DRUG OVERDOSE INTENTIONAL 156 0.0485
93 DELIRIUM TREMENS 19 0.0470
94 FIBROMYALGIA 1136 0.0467
95 LIVER INJURY 1143 0.0465
96 WALKING AID USER 304 0.0461
97 IMPAIRED HEALING 1475 0.0449
98 ACCIDENTAL DEATH 83 0.0446
99 MATERNAL EXPOSURE TIMING UNSPECIFIED 167 0.0444
100 SYSTEMIC LUPUS ERYTHEMATOSUS 1473 0.0415
101 FINGER DEFORMITY 196 0.0404
102 LIVE BIRTH 336 0.0401
103 VISCERAL CONGESTION 20 0.0391
104 EYE INJURY 119 0.0391
105 EXOSTOSIS 355 0.0388
106 BLEPHAROSPASM 244 0.0387
107 ALCOHOLIC LIVER DISEASE 13 0.0383
108 PHYSICAL ASSAULT 80 0.0383
109 TYPE 2 DIABETES MELLITUS 1283 0.0381
110 LUPUS-LIKE SYNDROME 336 0.0370
111 POISONING DELIBERATE 348 0.0367
112 TOXICITY TO VARIOUS AGENTS 6114 0.0362
113 ULCER HAEMORRHAGE 241 0.0356
114 OBESITY 567 0.0356
115 CONGENITAL UMBILICAL HERNIA 13 0.0349
116 SCIATICA 551 0.0345
117 PULMONARY FIBROSIS 663 0.0345
118 RASH VESICULAR 166 0.0343
119 CONTRAINDICATED PRODUCT ADMINISTERED 1037 0.0342
120 NAIL DISORDER 296 0.0338
121 ALCOHOLISM 144 0.0336
122 CARDIO-RESPIRATORY ARREST 1371 0.0328
123 CIRRHOSIS ALCOHOLIC 14 0.0306
124 GUN SHOT WOUND 58 0.0306
125 PSORIATIC ARTHROPATHY 1212 0.0298
126 LOWER LIMB FRACTURE 558 0.0290
127 POISONING 364 0.0289
128 OVERLAP SYNDROME 20 0.0286
129 LEGAL PROBLEM 21 0.0285
130 SUSPECTED SUICIDE ATTEMPT 17 0.0285
131 FOOT DEFORMITY 311 0.0280
132 ASPHYXIA 229 0.0280
133 RED BLOOD CELL SEDIMENTATION RATE INCREASED 310 0.0280
134 DRUG DETOXIFICATION 25 0.0280
135 BRADYPNOEA 75 0.0278
136 LOWER RESPIRATORY TRACT INFECTION 1250 0.0275
137 PRESCRIBED OVERDOSE 524 0.0271
138 DRUG SCREEN POSITIVE 213 0.0269
139 AMPHETAMINES POSITIVE 20 0.0267
140 MIOSIS 211 0.0263
141 MYOCARDIAL FIBROSIS 22 0.0262
142 JOINT DISLOCATION 275 0.0260
143 IMPAIRED DRIVING ABILITY 294 0.0258
144 HIP ARTHROPLASTY 394 0.0257
145 ROAD TRAFFIC ACCIDENT 1071 0.0256
146 BREAST CANCER STAGE II 208 0.0250
147 PRODUCT LABEL CONFUSION 145 0.0249
148 INTENTIONAL OVERDOSE 1569 0.0244
149 HEPATIC CIRRHOSIS 454 0.0241
150 THEFT 16 0.0241
151 GAIT INABILITY 772 0.0231
152 BLISTER 1295 0.0230
153 INTENTIONAL MISUSE 44 0.0230
154 ARTHROPATHY 1280 0.0230
155 BLOOD CHOLESTEROL INCREASED 1072 0.0230
156 SUICIDE ATTEMPT 1381 0.0228
157 ACCIDENTAL POISONING 31 0.0226
158 SELF INJURIOUS BEHAVIOUR 69 0.0226
159 HEPATIC ENZYME INCREASED 1523 0.0223
160 INFUSION RELATED REACTION 1477 0.0223
161 MULTIPLE DRUG OVERDOSE 109 0.0219
162 ILL-DEFINED DISORDER 1325 0.0218
163 JUDGEMENT IMPAIRED 31 0.0213
164 RESPIRATORY DEPRESSION 261 0.0213
165 BACK INJURY 231 0.0212
166 ANALGESIC DRUG LEVEL INCREASED 34 0.0212
167 INJURY 1482 0.0211
168 STOMATITIS 1278 0.0211
169 CONGENITAL ANOMALY 163 0.0210
170 GENERAL SYMPTOM 156 0.0208
171 DROWNING 21 0.0208
172 NIGHT SWEATS 653 0.0202
173 CARDIAC DEATH 24 0.0199
174 PRESCRIBED UNDERDOSE 393 0.0197
175 DELIRIUM 681 0.0196
176 MYOSITIS 176 0.0196
177 DISCOMFORT 1195 0.0196
178 SPONDYLITIS 71 0.0195
179 PARASOMNIA 14 0.0195
180 RESPIRATORY ARREST 537 0.0195
181 DRUG DIVERSION 120 0.0194
182 MYDRIASIS 247 0.0192
183 COUNTERFEIT PRODUCT ADMINISTERED 25 0.0192
184 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 97 0.0189
185 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 116 0.0188
186 COMA 891 0.0187
187 SLEEP DISORDER 1320 0.0187
188 THERAPEUTIC PRODUCT EFFECT DECREASED 836 0.0186
189 AREFLEXIA 49 0.0183
190 OSTEOARTHRITIS 776 0.0183
191 PRODUCT ADMINISTRATION INTERRUPTED 143 0.0182
192 ABNORMAL SLEEP-RELATED EVENT 24 0.0182
193 WHEEZING 1066 0.0180
194 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 14 0.0179
195 CARDIAC HYPERTROPHY 20 0.0179
196 SUBSTANCE USE 28 0.0179
197 PUPIL FIXED 31 0.0179
198 KNEE ARTHROPLASTY 371 0.0176
199 PERFORATION 14 0.0174
200 COELIAC DISEASE 169 0.0172
201 AMNESIA 1116 0.0171
202 COMA SCALE ABNORMAL 49 0.0169
203 DISINHIBITION 27 0.0168
204 BEZOAR 23 0.0167
205 OEDEMA 897 0.0165
206 IMPRISONMENT 29 0.0164
207 SOMNAMBULISM 107 0.0163
208 C-REACTIVE PROTEIN INCREASED 588 0.0161
209 NON-CARDIOGENIC PULMONARY OEDEMA 17 0.0161
210 RESPIRATORY ACIDOSIS 63 0.0160
211 SPINAL FUSION SURGERY 65 0.0160
212 LIVER DISORDER 705 0.0159
213 MOBILITY DECREASED 1127 0.0157
214 EUPHORIC MOOD 159 0.0155
215 SWELLING 1422 0.0152
216 SLEEP-RELATED EATING DISORDER 14 0.0149
217 LIVER FUNCTION TEST INCREASED 320 0.0149
218 PILOERECTION 16 0.0146
219 DISABILITY 282 0.0142
220 INFLAMMATION 734 0.0142
221 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 47 0.0142
222 DRUG-INDUCED LIVER INJURY 444 0.0141
223 NORMAL NEWBORN 75 0.0138
224 HEPATIC CONGESTION 13 0.0137
225 BEHAVIOUR DISORDER 74 0.0137
226 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 233 0.0136
227 LUNG DISORDER 662 0.0135
228 POTENTIATING DRUG INTERACTION 45 0.0134
229 FOAMING AT MOUTH 27 0.0134
230 ADVERSE REACTION 176 0.0133
231 BRAIN DEATH 40 0.0129
232 ALLERGY TO CHEMICALS 16 0.0128
233 HYPOTHERMIA 128 0.0126
234 INTENTIONAL PRODUCT USE ISSUE 1102 0.0126
235 JOINT SWELLING 1517 0.0126
236 SOPOR 164 0.0124
237 GASTROINTESTINAL DISORDER 1104 0.0123
238 RHEUMATOID ARTHRITIS 1397 0.0123
239 AGGRESSION 615 0.0123
240 PREGNANCY 246 0.0123
241 MUSCULOSKELETAL PAIN 634 0.0121
242 DEREALISATION 26 0.0121
243 DRUG TOXICITY 163 0.0120
244 PULSELESS ELECTRICAL ACTIVITY 50 0.0120
245 DISTRIBUTIVE SHOCK 27 0.0119
246 DRUG ABUSER 73 0.0119
247 MUSCULOSKELETAL STIFFNESS 1034 0.0118
248 SUICIDAL BEHAVIOUR 49 0.0118
249 JOINT STIFFNESS 309 0.0118
250 CONTUSION 1131 0.0117
251 GENERAL PHYSICAL HEALTH DETERIORATION 1356 0.0117
252 COMPLEX PARTIAL SEIZURES 13 0.0117
253 EAR INFECTION 311 0.0117
254 HEPATIC FIBROSIS 40 0.0116
255 CONFUSIONAL STATE 1857 0.0115
256 SINUSITIS 1165 0.0114
257 TASTE DISORDER 230 0.0113
258 NYSTAGMUS 60 0.0113
259 DRUG TOLERANCE 56 0.0111
260 NEOPLASM SKIN 17 0.0109
261 BACK DISORDER 175 0.0108
262 INFUSION SITE REACTION 32 0.0107
263 INTENTIONAL PRODUCT MISUSE 920 0.0105
264 ASPIRATION 115 0.0105
265 MATERNAL EXPOSURE DURING PREGNANCY 935 0.0105
266 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 176 0.0104
267 DRY MOUTH 839 0.0103
268 ACIDOSIS 79 0.0103
269 DRUG INTOLERANCE 998 0.0103
270 INTENTIONAL SELF-INJURY 206 0.0102
271 TEARFULNESS 43 0.0100
272 PERSONALITY DISORDER 26 0.0099
273 EPILEPSY 303 0.0099
274 ALTERED STATE OF CONSCIOUSNESS 213 0.0098
275 DEPRESSED LEVEL OF CONSCIOUSNESS 388 0.0098
276 BRAIN OEDEMA 123 0.0097
277 HEPATITIS 249 0.0097
278 MEDICATION ERROR 540 0.0097
279 ARTERIOSCLEROSIS CORONARY ARTERY 64 0.0097
280 OVERDOSE 2056 0.0095
281 CARDIAC ARREST 780 0.0094
282 ANTICHOLINERGIC SYNDROME 15 0.0094
283 TREATMENT FAILURE 778 0.0094
284 ACUTE HEPATIC FAILURE 128 0.0094
285 THERAPEUTIC AGENT TOXICITY 31 0.0093
286 HEPATIC NECROSIS 35 0.0093
287 PRODUCT COUNTERFEIT 16 0.0093
288 SINUS TACHYCARDIA 131 0.0092
289 PSYCHOMOTOR SKILLS IMPAIRED 24 0.0092
290 THERAPY NON-RESPONDER 411 0.0091
291 INFECTION 1313 0.0091
292 DYSPEPSIA 891 0.0090
293 HEPATIC ENCEPHALOPATHY 84 0.0090
294 GASTRIC DILATATION 15 0.0090
295 WEIGHT FLUCTUATION 94 0.0090
296 HYPERLACTACIDAEMIA 24 0.0089
297 RESPIRATORY RATE DECREASED 28 0.0089
298 TACHYCARDIA 788 0.0089
299 LOGORRHOEA 31 0.0088
300 BLOOD LACTIC ACID INCREASED 46 0.0087
301 RESPIRATORY ALKALOSIS 14 0.0086
302 HYPOVENTILATION 28 0.0086
303 CELL DEATH 17 0.0086
304 INTELLECTUAL DISABILITY 13 0.0086
305 BRADYARRHYTHMIA 14 0.0085
306 COMPARTMENT SYNDROME 22 0.0084
307 FREQUENT BOWEL MOVEMENTS 227 0.0084
308 HOMICIDAL IDEATION 34 0.0084
309 UNRESPONSIVE TO STIMULI 216 0.0084
310 AGITATION 614 0.0084
311 EXPOSURE VIA INGESTION 21 0.0083
312 SOCIAL AVOIDANT BEHAVIOUR 48 0.0083
313 HANGOVER 29 0.0082
314 HYPERSENSITIVITY 1519 0.0082
315 DRUG LEVEL INCREASED 135 0.0081
316 OSTEOPOROSIS 333 0.0081
317 ABDOMINAL DISCOMFORT 1349 0.0080
318 HYPERREFLEXIA 28 0.0080
319 HYPERTENSIVE HEART DISEASE 15 0.0080
320 MIGRAINE 764 0.0080
321 PERIPHERAL SWELLING 1217 0.0079
322 HYPOAESTHESIA 1176 0.0078
323 SELF-MEDICATION 32 0.0078
324 INCOHERENT 50 0.0077
325 ARTERIOSCLEROSIS 72 0.0076
326 RENAL TUBULAR NECROSIS 75 0.0076
327 VENTRICULAR HYPERTROPHY 19 0.0076
328 PNEUMONIA ASPIRATION 187 0.0075
329 SEDATION COMPLICATION 19 0.0074
330 NASOPHARYNGITIS 1362 0.0074
331 BREATH ODOUR 18 0.0074
332 METABOLIC ACIDOSIS 235 0.0073
333 GRAND MAL CONVULSION 67 0.0072
334 PERSECUTORY DELUSION 18 0.0072
335 HYPERTRANSAMINASAEMIA 50 0.0072
336 PSYCHIATRIC DECOMPENSATION 14 0.0072
337 MULTIPLE INJURIES 45 0.0071
338 EXPOSURE DURING PREGNANCY 444 0.0071
339 PSYCHOMOTOR RETARDATION 20 0.0071
340 HOSTILITY 18 0.0071
341 ABNORMAL BEHAVIOUR 279 0.0070
342 URTICARIA 1178 0.0070
343 DYSARTHRIA 263 0.0070
344 ALOPECIA 1369 0.0070
345 MEMORY IMPAIRMENT 956 0.0070
346 IMPULSIVE BEHAVIOUR 26 0.0069
347 INTERVERTEBRAL DISCITIS 13 0.0069
348 PRE-EXISTING CONDITION IMPROVED 43 0.0069
349 HYPERTENSION 1457 0.0069
350 SEROTONIN SYNDROME 132 0.0069
351 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 18 0.0069
352 MAJOR DEPRESSION 50 0.0068
353 DISTURBANCE IN SOCIAL BEHAVIOUR 16 0.0068
354 INTERNATIONAL NORMALISED RATIO FLUCTUATION 14 0.0068
355 ELECTROCARDIOGRAM QT PROLONGED 238 0.0066
356 SLOW SPEECH 16 0.0066
357 ACCIDENTAL OVERDOSE 241 0.0066
358 SHOCK 151 0.0066
359 MYOCARDITIS 75 0.0065
360 SUDDEN DEATH 69 0.0065
361 SUICIDAL IDEATION 596 0.0065
362 DRUG WITHDRAWAL SYNDROME NEONATAL 96 0.0065
363 WEIGHT INCREASED 1440 0.0064
364 PULMONARY CONGESTION 84 0.0064
365 IMPULSE-CONTROL DISORDER 13 0.0063
366 PARANOIA 108 0.0063
367 PULMONARY OEDEMA 280 0.0062
368 CLONUS 17 0.0062
369 EYE CONTUSION 13 0.0061
370 RESPIRATORY DISORDER 184 0.0061
371 CARDIOMEGALY 75 0.0061
372 LOSS OF CONSCIOUSNESS 776 0.0061
373 ANTIPSYCHOTIC DRUG LEVEL INCREASED 17 0.0060
374 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 290 0.0060
375 BRAIN HERNIATION 18 0.0060
376 PROTHROMBIN TIME PROLONGED 36 0.0060
377 DRUG INTERACTION 952 0.0060
378 POST-TRAUMATIC STRESS DISORDER 40 0.0060
379 SELF-INJURIOUS IDEATION 25 0.0060
380 CARDIOGENIC SHOCK 85 0.0059
381 APNOEA 46 0.0059
382 DRUG DEPENDENCE 943 0.0059
383 HEPATIC STEATOSIS 109 0.0058
384 TACHYPHRENIA 20 0.0058
385 WHITE BLOOD CELL COUNT INCREASED 221 0.0058
386 RECTAL HAEMORRHAGE 247 0.0057
387 HEPATOMEGALY 56 0.0057
388 ENURESIS 23 0.0057
389 PULSE ABSENT 27 0.0057
390 OEDEMA PERIPHERAL 690 0.0057
391 RHABDOMYOLYSIS 235 0.0056
392 FLAT AFFECT 13 0.0056
393 CRANIOCEREBRAL INJURY 17 0.0056
394 SOCIAL PROBLEM 23 0.0056
395 ASTHMA 626 0.0055
396 CLUMSINESS 15 0.0055
397 DRUG LEVEL ABOVE THERAPEUTIC 25 0.0055
398 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
399 INSOMNIA 1423 0.0053
400 PANCREATITIS 282 0.0053
401 DEPRESSION 1205 0.0053
402 BRAIN INJURY 53 0.0053
403 CIRCULATORY COLLAPSE 90 0.0053
404 RESTLESSNESS 193 0.0053
405 INJECTION SITE ABSCESS 13 0.0052
406 FUNCTIONAL GASTROINTESTINAL DISORDER 18 0.0052
407 ADVERSE EVENT 479 0.0052
408 VENTRICULAR ARRHYTHMIA 19 0.0052
409 COLITIS ULCERATIVE 232 0.0052
410 LABORATORY TEST ABNORMAL 153 0.0052
411 SCREAMING 33 0.0052
412 SOMNOLENCE 1031 0.0051
413 CYANOSIS 80 0.0051
414 HYPERTONIA 29 0.0051
415 CHEST PAIN 937 0.0051
416 ENCEPHALOPATHY 124 0.0050
417 GENERALISED TONIC-CLONIC SEIZURE 83 0.0050
418 BLOOD CULTURE POSITIVE 15 0.0050
419 HEPATIC FAILURE 151 0.0050
420 STUPOR 16 0.0050
421 VENTRICULAR TACHYCARDIA 82 0.0050
422 ABDOMINAL PAIN UPPER 1011 0.0049
423 CARDIOPULMONARY FAILURE 19 0.0049
424 PULMONARY HAEMORRHAGE 38 0.0049
425 HAEMODYNAMIC INSTABILITY 37 0.0049
426 HEPATOTOXICITY 108 0.0048
427 DRUG WITHDRAWAL SYNDROME 424 0.0048
428 MUSCLE SPASTICITY 59 0.0048
429 LYME DISEASE 16 0.0048
430 MYOCLONUS 57 0.0048
431 SNORING 18 0.0048
432 MENTAL STATUS CHANGES 132 0.0047
433 INTENTIONAL DOSE OMISSION 134 0.0047
434 EAR PAIN 91 0.0047
435 LEFT VENTRICULAR HYPERTROPHY 20 0.0047
436 VENTRICULAR HYPOKINESIA 15 0.0047
437 DIFFICULTY IN WALKING 16 0.0046
438 DISORIENTATION 184 0.0046
439 ARTHRITIS 365 0.0046
440 PSYCHOMOTOR HYPERACTIVITY 77 0.0046
441 LOSS OF EMPLOYMENT 14 0.0046
442 HYPOMANIA 17 0.0046
443 MUSCULAR WEAKNESS 525 0.0046
444 HYPOPNOEA 16 0.0046
445 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 323 0.0045
446 NECK PAIN 253 0.0045
447 HAEMODIALYSIS 38 0.0045
448 CONDITION AGGRAVATED 1373 0.0045
449 INTENTIONAL DRUG MISUSE 94 0.0045
450 BLOOD CREATINE PHOSPHOKINASE INCREASED 129 0.0045
451 ACUTE PULMONARY OEDEMA 25 0.0044
452 FACIAL BONES FRACTURE 16 0.0044
453 PARAESTHESIA 699 0.0044
454 FEELING DRUNK 33 0.0044
455 NON-CARDIAC CHEST PAIN 14 0.0044
456 VENTRICULAR FIBRILLATION 49 0.0044
457 PSYCHOTIC DISORDER 129 0.0044
458 BUNDLE BRANCH BLOCK RIGHT 20 0.0044
459 ANOREXIA 56 0.0043
460 UPPER RESPIRATORY TRACT INFECTION 199 0.0043
461 PRODUCT USE ISSUE 808 0.0043
462 LEUKOENCEPHALOPATHY 16 0.0043
463 FEELING OF DESPAIR 20 0.0043
464 COAGULOPATHY 71 0.0043
465 DEPRESSIVE SYMPTOM 15 0.0043
466 BUNDLE BRANCH BLOCK LEFT 18 0.0042
467 WITHDRAWAL SYNDROME 177 0.0042
468 FEELING HOT 254 0.0041
469 LACTIC ACIDOSIS 134 0.0041
470 MUSCLE SPASMS 755 0.0041
471 BREAST CANCER STAGE I 38 0.0041
472 DECREASED APPETITE 952 0.0041
473 GAIT DISTURBANCE 776 0.0041
474 BIPOLAR DISORDER 44 0.0040
475 VOMITING 1896 0.0040
476 PARTIAL SEIZURES 21 0.0040
477 GASTROOESOPHAGEAL REFLUX DISEASE 321 0.0040
478 ATRIOVENTRICULAR BLOCK FIRST DEGREE 17 0.0039
479 INJECTION SITE REACTION 268 0.0039
480 SEDATION 102 0.0039
481 FLUID RETENTION 198 0.0039
482 STOMACH DISCOMFORT 20 0.0039
483 PYREXIA 1339 0.0039
484 CONVULSION 221 0.0039
485 HYPOGLYCAEMIA 187 0.0039
486 ACCIDENT 46 0.0038
487 SLUGGISHNESS 39 0.0038
488 ANXIETY 1081 0.0038
489 ADVERSE DRUG REACTION 339 0.0038
490 APATHY 55 0.0038
491 PERSONALITY CHANGE 35 0.0038
492 HYPOTENSION 752 0.0037
493 PANIC REACTION 27 0.0037
494 RASH 1630 0.0037
495 MANIA 61 0.0037
496 ATAXIA 44 0.0037
497 HYPOXIA 130 0.0037
498 DELUSION 57 0.0037
499 HYPERTHERMIA 28 0.0037
500 THINKING ABNORMAL 68 0.0036
501 CARDIAC FAILURE ACUTE 24 0.0036
502 CORONARY ARTERY STENOSIS 18 0.0036
503 BRADYPHRENIA 23 0.0035
504 RESPIRATION ABNORMAL 24 0.0035
505 PRODUCT USE IN UNAPPROVED INDICATION 857 0.0035
506 PAIN IN EXTREMITY 1011 0.0034
507 PRURITUS 1315 0.0034
508 ARTHRALGIA 1416 0.0034
509 HYPERAMMONAEMIA 17 0.0034
510 DISSOCIATION 26 0.0034
511 HEPATITIS ACUTE 22 0.0034
512 OLIGURIA 21 0.0034
513 CONGESTIVE CARDIOMYOPATHY 14 0.0034
514 MULTIPLE ORGAN DYSFUNCTION SYNDROME 95 0.0034
515 ACUTE RESPIRATORY FAILURE 64 0.0033
516 ATTENTION DEFICIT HYPERACTIVITY DISORDER 14 0.0033
517 PNEUMONIA 1069 0.0033
518 SALIVARY HYPERSECRETION 33 0.0033
519 EMPHYSEMA 33 0.0033
520 WEIGHT DECREASED 911 0.0033
521 CANDIDIASIS 13 0.0032
522 PHARMACEUTICAL PRODUCT COMPLAINT 84 0.0032
523 CONCUSSION 25 0.0032
524 HALLUCINATION, VISUAL 68 0.0032
525 TREATMENT NONCOMPLIANCE 176 0.0032
526 HALLUCINATION, AUDITORY 51 0.0032
527 VISUAL IMPAIRMENT 395 0.0032
528 HYPOKALAEMIA 147 0.0032
529 THERAPEUTIC RESPONSE DECREASED 193 0.0032
530 ARTHRITIS BACTERIAL 13 0.0032
531 TACHYPNOEA 43 0.0032
532 FOETAL EXPOSURE DURING PREGNANCY 256 0.0031
533 HEAD INJURY 99 0.0031
534 TENSION 19 0.0031
535 SEIZURE 360 0.0031
536 ACUTE RESPIRATORY DISTRESS SYNDROME 55 0.0031
537 HAEMOLYSIS 24 0.0031
538 HYPERVENTILATION 18 0.0031
539 ELECTROLYTE IMBALANCE 36 0.0031
540 BODY TEMPERATURE INCREASED 63 0.0031
541 COORDINATION ABNORMAL 43 0.0031
542 ANGER 104 0.0031
543 ENERGY INCREASED 18 0.0030
544 EJECTION FRACTION DECREASED 47 0.0030
545 FORMICATION 21 0.0030
546 INTENTIONAL UNDERDOSE 22 0.0030
547 GASTRITIS EROSIVE 14 0.0030
548 LIVER FUNCTION TEST ABNORMAL 87 0.0030
549 DISSEMINATED INTRAVASCULAR COAGULATION 42 0.0030
550 THERMAL BURN 21 0.0030
551 SUBARACHNOID HAEMORRHAGE 30 0.0029
552 PETIT MAL EPILEPSY 15 0.0029
553 DYSPNOEA 1663 0.0029
554 GAMMA-GLUTAMYLTRANSFERASE INCREASED 65 0.0029
555 TORSADE DE POINTES 23 0.0029
556 ELECTROCARDIOGRAM ABNORMAL 23 0.0029
557 LEUKOCYTOSIS 53 0.0029
558 PAIN 1787 0.0029
559 MYOCARDIAL ISCHAEMIA 33 0.0029
560 RENAL FAILURE ACUTE 123 0.0029
561 ATELECTASIS 28 0.0029
562 IRON DEFICIENCY 13 0.0029
563 MENTAL IMPAIRMENT 70 0.0029
564 DEVELOPMENTAL DELAY 26 0.0029
565 SCHIZOPHRENIA 35 0.0029
566 BRADYKINESIA 17 0.0029
567 TRANSAMINASES INCREASED 64 0.0029
568 SKIN LACERATION 31 0.0028
569 ABDOMINAL PAIN 659 0.0028
570 HALLUCINATION 212 0.0028
571 BRADYCARDIA 149 0.0028
572 UNDERDOSE 205 0.0028
573 HYPOTONIA 28 0.0028
574 ANURIA 24 0.0028
575 MALAISE 1217 0.0028
576 DRUG EXPOSURE DURING PREGNANCY 94 0.0028
577 ABDOMINAL DISTENSION 288 0.0028
578 METABOLIC DISORDER 16 0.0028
579 PSORIASIS 357 0.0027
580 LETHARGY 157 0.0027
581 DEPRESSED MOOD 144 0.0027
582 ABNORMAL DREAMS 75 0.0027
583 DRUG ADMINISTRATION ERROR 83 0.0027
584 PRODUCT ADMINISTRATION ERROR 54 0.0027
585 HEPATIC CYTOLYSIS 34 0.0027
586 CATATONIA 14 0.0027
587 POLYARTHRITIS 14 0.0027
588 MENTAL DISORDER 115 0.0026
589 ALANINE AMINOTRANSFERASE INCREASED 162 0.0026
590 ASPARTATE AMINOTRANSFERASE INCREASED 140 0.0026
591 VISUAL DISTURBANCE 15 0.0026
592 REFUSAL OF TREATMENT BY PATIENT 17 0.0026
593 NIGHTMARE 90 0.0026
594 CONCOMITANT DISEASE AGGRAVATED 16 0.0026
595 DIZZINESS 1287 0.0026
596 BRONCHITIS 190 0.0026
597 AKATHISIA 35 0.0026
598 MITRAL VALVE INCOMPETENCE 29 0.0026
599 MOTOR DYSFUNCTION 26 0.0025
600 DECREASED INTEREST 15 0.0025
601 SLEEP APNOEA SYNDROME 48 0.0025
602 AFFECT LABILITY 24 0.0025
603 MULTI-ORGAN FAILURE 43 0.0025
604 STATUS EPILEPTICUS 28 0.0025
605 RENAL FAILURE CHRONIC 19 0.0025
606 ASTHENIA 925 0.0025
607 INTERNATIONAL NORMALISED RATIO INCREASED 70 0.0025
608 IRRITABILITY 147 0.0024
609 ECONOMIC PROBLEM 37 0.0024
610 OXYGEN SATURATION DECREASED 137 0.0024
611 AFFECTIVE DISORDER 19 0.0024
612 PAPULE 17 0.0024
613 BRUXISM 13 0.0024
614 HEPATITIS C 29 0.0024
615 DISTURBANCE IN ATTENTION 129 0.0024
616 MOOD SWINGS 76 0.0024
617 SINUS BRADYCARDIA 23 0.0024
618 FATIGUE 1848 0.0024
619 DERMATITIS CONTACT 27 0.0024
620 RESTLESS LEGS SYNDROME 43 0.0024
621 HEADACHE 1479 0.0024
622 NAUSEA 1853 0.0023
623 RESPIRATORY DISTRESS 64 0.0023
624 MUSCLE TWITCHING 53 0.0023
625 DUODENAL ULCER 16 0.0023
626 NEUTROPHIL COUNT INCREASED 23 0.0022
627 NERVOUS SYSTEM DISORDER 70 0.0022
628 INITIAL INSOMNIA 23 0.0022
629 CRYING 81 0.0022
630 MATERNAL DRUGS AFFECTING FOETUS 17 0.0022
631 VENTRICULAR EXTRASYSTOLES 23 0.0022
632 RASH PRURITIC 120 0.0022
633 ATRIOVENTRICULAR BLOCK 17 0.0022
634 POLYURIA 18 0.0022
635 FACE OEDEMA 37 0.0022
636 CHOLESTASIS 42 0.0022
637 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
638 URINE OUTPUT DECREASED 19 0.0022
639 ERECTILE DYSFUNCTION 55 0.0021
640 RESPIRATORY RATE INCREASED 19 0.0021
641 DEATH 1828 0.0021
642 TREMOR 351 0.0021
643 COGNITIVE DISORDER 98 0.0021
644 PANCREATITIS ACUTE 47 0.0021
645 MIDDLE INSOMNIA 39 0.0021
646 EMOTIONAL DISORDER 64 0.0021
647 PRODUCT QUALITY ISSUE 280 0.0021
648 PANIC ATTACK 75 0.0021
649 EYE MOVEMENT DISORDER 14 0.0020
650 BLOOD BILIRUBIN INCREASED 55 0.0020
651 PSYCHIATRIC SYMPTOM 15 0.0020
652 BLOOD UREA INCREASED 34 0.0020
653 HYPERBILIRUBINAEMIA 21 0.0020
654 LACERATION 19 0.0020
655 TRICUSPID VALVE INCOMPETENCE 16 0.0020
656 HYPERHIDROSIS 259 0.0020
657 HUNGER 28 0.0020
658 HYPERLIPIDAEMIA 24 0.0020
659 THROMBOCYTOPENIA 222 0.0020
660 FALL 657 0.0020
661 HAEMATEMESIS 50 0.0020
662 DIARRHOEA 1269 0.0020
663 ARRHYTHMIA 93 0.0020
664 SUBDURAL HAEMATOMA 28 0.0020
665 PARALYSIS 28 0.0020
666 POOR QUALITY SLEEP 42 0.0019
667 ULCER 31 0.0019
668 KNEE OPERATION 19 0.0019
669 LEUKOPENIA 96 0.0019
670 FEAR 51 0.0019
671 CARDIOMYOPATHY 28 0.0019
672 FEELING JITTERY 36 0.0019
673 ATRIAL FLUTTER 15 0.0019
674 EATING DISORDER 40 0.0019
675 MOOD ALTERED 51 0.0019
676 HYSTERECTOMY 16 0.0018
677 HYPERAESTHESIA 15 0.0018
678 RESPIRATORY FAILURE 133 0.0018
679 SURGERY 106 0.0018
680 CARDIOTOXICITY 16 0.0018
681 SPLENOMEGALY 21 0.0018
682 HYPOKINESIA 26 0.0018
683 INCORRECT ROUTE OF DRUG ADMINISTRATION 64 0.0018
684 HYPERSOMNIA 51 0.0018
685 NEUROLEPTIC MALIGNANT SYNDROME 21 0.0018
686 SECRETION DISCHARGE 22 0.0018
687 APHASIA 53 0.0018
688 ACUTE KIDNEY INJURY 267 0.0017
689 HOSPITALISATION 266 0.0017
690 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
691 HYPERGLYCAEMIA 63 0.0017
692 DENTAL CARIES 19 0.0017
693 OFF LABEL USE 1500 0.0017
694 BLOOD SODIUM DECREASED 32 0.0017
695 DIALYSIS 24 0.0017
696 IMPAIRED WORK ABILITY 36 0.0017
697 BRONCHOSPASM 24 0.0017
698 ATRIAL SEPTAL DEFECT 14 0.0017
699 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
700 ANAL INCONTINENCE 15 0.0017
701 STAPHYLOCOCCAL INFECTION 55 0.0017
702 HYPERKALAEMIA 58 0.0017
703 PERICARDIAL EFFUSION 38 0.0016
704 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
705 BLOOD ALBUMIN DECREASED 13 0.0016
706 SCAR 28 0.0016
707 CAESAREAN SECTION 19 0.0016
708 BODY TEMPERATURE DECREASED 16 0.0016
709 THIRST 29 0.0016
710 ATRIAL FIBRILLATION 158 0.0016
711 SEXUAL DYSFUNCTION 19 0.0016
712 MALNUTRITION 18 0.0016
713 JAUNDICE 43 0.0016
714 BLOOD POTASSIUM DECREASED 48 0.0016
715 ABORTION INDUCED 15 0.0016
716 LUNG INFILTRATION 14 0.0016
717 DYSKINESIA 64 0.0016
718 WRONG DRUG ADMINISTERED 14 0.0016
719 QUALITY OF LIFE DECREASED 21 0.0016
720 URINARY RETENTION 52 0.0016
721 NERVOUSNESS 81 0.0015
722 HEART RATE INCREASED 153 0.0015
723 SPINAL OPERATION 19 0.0015
724 INADEQUATE ANALGESIA 13 0.0015
725 PERIPHERAL COLDNESS 21 0.0015
726 HEPATIC FUNCTION ABNORMAL 57 0.0015
727 BALANCE DISORDER 132 0.0015
728 CORONARY ARTERY DISEASE 46 0.0015
729 POST PROCEDURAL COMPLICATION 29 0.0015
730 HYPOMAGNESAEMIA 21 0.0015
731 PALLOR 41 0.0015
732 CARDIAC MURMUR 13 0.0015
733 ANKLE FRACTURE 23 0.0015
734 NOCTURIA 18 0.0015
735 HEPATOCELLULAR INJURY 21 0.0015
736 INCORRECT PRODUCT ADMINISTRATION DURATION 32 0.0015
737 BLOOD GLUCOSE DECREASED 70 0.0015
738 URINARY INCONTINENCE 43 0.0014
739 PLEURAL EFFUSION 88 0.0014
740 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
741 HYPONATRAEMIA 81 0.0014
742 VITAMIN D DEFICIENCY 14 0.0014
743 MUSCLE RIGIDITY 17 0.0014
744 HEMIPARESIS 24 0.0014
745 GASTRITIS 37 0.0014
746 ADRENAL INSUFFICIENCY 17 0.0014
747 BLOOD CREATININE INCREASED 91 0.0014
748 PNEUMOTHORAX 22 0.0014
749 BLOOD PRESSURE DECREASED 92 0.0014
750 RESPIRATORY TRACT INFECTION 36 0.0014
751 PLATELET COUNT INCREASED 18 0.0014
752 WRONG TECHNIQUE IN DRUG USAGE PROCESS 50 0.0014
753 SPEECH DISORDER 72 0.0014
754 INTERVERTEBRAL DISC PROTRUSION 30 0.0014
755 COLD SWEAT 24 0.0014
756 HAEMATOCRIT DECREASED 27 0.0014
757 BLOOD TRIGLYCERIDES INCREASED 24 0.0014
758 JOINT INJURY 29 0.0014
759 DIZZINESS POSTURAL 13 0.0013
760 DYSTONIA 26 0.0013
761 INCONTINENCE 14 0.0013
762 RETCHING 28 0.0013
763 RIB FRACTURE 27 0.0013
764 CARDIAC FAILURE 105 0.0013
765 NODULE 17 0.0013
766 SYNCOPE 130 0.0013
767 UNEVALUABLE EVENT 98 0.0013
768 BEDRIDDEN 17 0.0013
769 HEART RATE DECREASED 45 0.0013
770 SEASONAL ALLERGY 18 0.0013
771 FOOT FRACTURE 24 0.0013
772 HAEMATURIA 43 0.0013
773 DYSURIA 46 0.0012
774 CHROMATURIA 28 0.0012
775 HIATUS HERNIA 16 0.0012
776 BREAST CANCER FEMALE 33 0.0012
777 FEELING ABNORMAL 296 0.0012
778 CHOLELITHIASIS 40 0.0012
779 LIMB INJURY 33 0.0012
780 DEHYDRATION 162 0.0012
781 ABASIA 30 0.0012
782 ILEUS 15 0.0012
783 DECREASED ACTIVITY 13 0.0012
784 OCULAR HYPERAEMIA 57 0.0012
785 NEURALGIA 29 0.0012
786 BLOOD GLUCOSE FLUCTUATION 13 0.0012
787 MELAENA 26 0.0012
788 GOUT 21 0.0012
789 DRUG EFFECT DECREASED 63 0.0012
790 NERVE INJURY 13 0.0012
791 PRODUCT PREPARATION ERROR 24 0.0012
792 DRUG INEFFECTIVE 1539 0.0012
793 VERTIGO 71 0.0012
794 RENAL FAILURE 153 0.0012
795 INCREASED APPETITE 22 0.0012
796 PREMATURE BABY 34 0.0011
797 ABSCESS 18 0.0011
798 ASCITES 33 0.0011
799 CEREBRAL HAEMORRHAGE 40 0.0011
800 BLOOD POTASSIUM INCREASED 18 0.0011
801 MUSCULOSKELETAL DISCOMFORT 19 0.0011
802 PALPITATIONS 129 0.0011
803 SKIN LESION 30 0.0011
804 TINNITUS 50 0.0011
805 POLLAKIURIA 45 0.0011
806 RENAL DISORDER 50 0.0011
807 CARDIOVASCULAR DISORDER 27 0.0011
808 THERAPEUTIC RESPONSE UNEXPECTED 47 0.0010
809 EXTRAPYRAMIDAL DISORDER 26 0.0010
810 HAEMATOMA 27 0.0010
811 ANOSMIA 15 0.0010
812 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 54 0.0010
813 ERUCTATION 20 0.0010
814 ABORTION SPONTANEOUS 41 0.0010
815 BLOOD GLUCOSE INCREASED 191 0.0010
816 DEPENDENCE 55 0.0010
817 NEPHROLITHIASIS 46 0.0010
818 BLOOD URINE PRESENT 19 0.0010
819 BACK PAIN 231 0.0010
820 DYSSTASIA 29 0.0010
821 ANHEDONIA 26 0.0010
822 MUSCLE TIGHTNESS 16 0.0010
823 FLATULENCE 56 0.0010
824 HERNIA 19 0.0010
825 ORTHOSTATIC HYPOTENSION 17 0.0010
826 GASTROINTESTINAL HAEMORRHAGE 80 0.0010
827 PHOTOPHOBIA 18 0.0010
828 DEAFNESS 25 0.0010
829 GASTRIC ULCER 18 0.0009
830 ANGINA PECTORIS 27 0.0009
831 BLOOD PRESSURE INCREASED 144 0.0009
832 HAEMORRHAGE INTRACRANIAL 14 0.0009
833 PELVIC PAIN 17 0.0009
834 ACCIDENTAL EXPOSURE TO PRODUCT 96 0.0009
835 CARPAL TUNNEL SYNDROME 13 0.0009
836 PULMONARY HYPERTENSION 19 0.0009
837 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
838 MUSCULOSKELETAL CHEST PAIN 14 0.0009
839 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
840 MYALGIA 152 0.0009
841 CHILLS 104 0.0009
842 OSTEOMYELITIS 16 0.0009
843 ACUTE MYOCARDIAL INFARCTION 26 0.0009
844 APPLICATION SITE ERYTHEMA 23 0.0009
845 FAECES DISCOLOURED 19 0.0009
846 FLUSHING 89 0.0009
847 VISUAL ACUITY REDUCED 29 0.0009
848 IMMUNODEFICIENCY 13 0.0009
849 HAEMORRHAGE 90 0.0009
850 CEREBRAL INFARCTION 21 0.0009
851 BLOOD PRESSURE ABNORMAL 17 0.0009
852 UPPER LIMB FRACTURE 17 0.0009
853 ANAPHYLACTIC REACTION 47 0.0008
854 VIRAL INFECTION 28 0.0008
855 CARDIAC FAILURE CONGESTIVE 67 0.0008
856 VISION BLURRED 114 0.0008
857 HYPOPHAGIA 21 0.0008
858 EYE DISORDER 27 0.0008
859 HYPOTHYROIDISM 26 0.0008
860 INFLUENZA LIKE ILLNESS 67 0.0008
861 DERMATITIS 17 0.0008
862 BACTERIAL INFECTION 15 0.0008
863 SPINAL FRACTURE 16 0.0008
864 LYMPHADENOPATHY 28 0.0008
865 FEELING COLD 22 0.0008
866 DIABETES MELLITUS 60 0.0008
867 EMOTIONAL DISTRESS 95 0.0008
868 THROAT TIGHTNESS 21 0.0008
869 SKIN ULCER 20 0.0008
870 TOOTHACHE 14 0.0008
871 DIPLOPIA 20 0.0008
872 RED BLOOD CELL COUNT DECREASED 22 0.0008
873 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
874 SWELLING FACE 50 0.0008
875 AGEUSIA 19 0.0008
876 LACRIMATION INCREASED 23 0.0008
877 DEEP VEIN THROMBOSIS 49 0.0008
878 SEPSIS 84 0.0008
879 EPISTAXIS 56 0.0007
880 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
881 HAEMOGLOBIN DECREASED 76 0.0007
882 SKIN DISCOLOURATION 34 0.0007
883 CONSTIPATION 161 0.0007
884 PRODUCT PRESCRIBING ISSUE 16 0.0007
885 MYOCARDIAL INFARCTION 127 0.0007
886 GASTROENTERITIS VIRAL 13 0.0007
887 TOOTH DISORDER 16 0.0007
888 HEART RATE IRREGULAR 16 0.0007
889 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
890 DYSGEUSIA 52 0.0007
891 RASH GENERALISED 18 0.0007
892 CARDIAC DISORDER 65 0.0007
893 PRURITUS GENERALISED 15 0.0007
894 ANAEMIA 132 0.0007
895 CYSTITIS 22 0.0007
896 MULTIPLE SCLEROSIS 33 0.0007
897 SEPTIC SHOCK 30 0.0007
898 HAEMOPTYSIS 19 0.0007
899 GLYCOSYLATED HAEMOGLOBIN INCREASED 17 0.0007
900 HAEMORRHOIDS 13 0.0007
901 MOUTH ULCERATION 14 0.0007
902 LOCALISED INFECTION 16 0.0007
903 RASH MACULAR 23 0.0007
904 PLATELET COUNT DECREASED 70 0.0007
905 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
906 HOT FLUSH 49 0.0006
907 PRODUCTIVE COUGH 31 0.0006
908 DRY EYE 32 0.0006
909 OSTEONECROSIS 21 0.0006
910 BURNING SENSATION 44 0.0006
911 PANCYTOPENIA 35 0.0006
912 NEUROPATHY PERIPHERAL 59 0.0006
913 NO ADVERSE EVENT 112 0.0006
914 BLINDNESS 25 0.0006
915 DYSPNOEA EXERTIONAL 23 0.0006
916 CHEST DISCOMFORT 62 0.0006
917 DYSPHAGIA 57 0.0006
918 ERYTHEMA 122 0.0006
919 HAEMATOCHEZIA 32 0.0006
920 PULMONARY EMBOLISM 55 0.0006
921 PRESYNCOPE 14 0.0006
922 CELLULITIS 28 0.0006
923 CATARACT 33 0.0006
924 INJECTION SITE RASH 17 0.0006
925 RENAL IMPAIRMENT 46 0.0005
926 ANAPHYLACTIC SHOCK 14 0.0005
927 BLOOD PRESSURE FLUCTUATION 13 0.0005
928 RHINORRHOEA 35 0.0005
929 ILLNESS 55 0.0005
930 SKIN EXFOLIATION 45 0.0005
931 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
932 DYSPHONIA 31 0.0005
933 GASTRIC DISORDER 18 0.0005
934 LIMB DISCOMFORT 16 0.0005
935 WHITE BLOOD CELL COUNT DECREASED 56 0.0005
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 93 0.0005
937 EYE PAIN 29 0.0005
938 SWOLLEN TONGUE 16 0.0005
939 RENAL INJURY 15 0.0005
940 PRODUCT ADHESION ISSUE 18 0.0005
941 RASH ERYTHEMATOUS 24 0.0005
942 URINARY TRACT INFECTION 85 0.0005
943 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 99 0.0005
944 THROMBOSIS 39 0.0005
945 DISEASE RECURRENCE 23 0.0005
946 FUNGAL INFECTION 16 0.0005
947 SKIN DISORDER 16 0.0005
948 CHRONIC KIDNEY DISEASE 36 0.0005
949 THROAT IRRITATION 21 0.0005
950 THERAPY CESSATION 24 0.0005
951 MOVEMENT DISORDER 15 0.0005
952 BONE PAIN 27 0.0005
953 INFLUENZA 51 0.0005
954 INJECTION SITE HAEMORRHAGE 36 0.0005
955 EXTRA DOSE ADMINISTERED 18 0.0004
956 NASAL CONGESTION 26 0.0004
957 NEUTROPHIL COUNT DECREASED 18 0.0004
958 INJECTION SITE BRUISING 35 0.0004
959 MULTIPLE SCLEROSIS RELAPSE 30 0.0004
960 EYE SWELLING 16 0.0004
961 FEBRILE NEUTROPENIA 28 0.0004
962 COLITIS 16 0.0004
963 CEREBROVASCULAR ACCIDENT 71 0.0004
964 PRODUCT SUBSTITUTION ISSUE 24 0.0004
965 OROPHARYNGEAL PAIN 38 0.0004
966 INTERSTITIAL LUNG DISEASE 19 0.0004
967 DISEASE PROGRESSION 46 0.0004
968 VAGINAL HAEMORRHAGE 16 0.0004
969 INCORRECT DOSE ADMINISTERED 84 0.0004
970 PRODUCT DOSE OMISSION ISSUE 107 0.0004
971 INJECTION SITE ERYTHEMA 44 0.0004
972 EYE IRRITATION 20 0.0003
973 INTESTINAL OBSTRUCTION 13 0.0003
974 BREAST CANCER 32 0.0003
975 COVID-19 60 0.0003
976 NEUTROPENIA 46 0.0003
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
978 COUGH 92 0.0003
979 HYPOACUSIS 14 0.0003
980 DRY SKIN 43 0.0003
981 SKIN IRRITATION 14 0.0003
982 NEOPLASM MALIGNANT 20 0.0003
983 HERPES ZOSTER 17 0.0003
984 ANGIOEDEMA 13 0.0003
985 INJECTION SITE PRURITUS 19 0.0003
986 MALIGNANT NEOPLASM PROGRESSION 28 0.0003
987 ECZEMA 14 0.0003
988 SKIN BURNING SENSATION 17 0.0002
989 INJECTION SITE PAIN 65 0.0002
990 INJECTION SITE SWELLING 16 0.0002
991 ACNE 15 0.0002
992 DEVICE ISSUE 15 0.0002
993 DRUG DOSE OMISSION 27 0.0002